Lymphadenopathy after BNT162b2 Covid-19 Vaccine: Preliminary Ultrasound Findings

• Published in: Biology (Basel, Switzerland) Switzerland), 2021-03, Vol.10 (3), p.214
• Main Authors: Granata, Vincenza, Fusco, Roberta, Setola, Sergio Venanzio, Galdiero, Roberta, Picone, Carmine, Izzo, Francesco, D'Aniello, Roberta, Miele, Vittorio, Grassi, Roberta, Grassi, Roberto, Petrillo, Antonella
• Format: Article
• Language: English
• Subjects: COVID-19 infection; lymphadenopathy; ultrasound; vaccine
• ISSN: 2079-7737; 2079-7737
• DOI: 10.3390/biology10030214

During a spontaneous and autonomous study, we assessed the ultrasound finding of lymphadenopathy after Pfizer vaccine. We enrolled 18 patients with 58 lymphadenopathies: in 10 patients, they were in the laterocervical side, while in 8 patients in the axillar site. The largest diameter was 16 mm with a range from 7 to 16 mm (median value = 10 mm). In the same patient, we found different ultrasound nodal findings. A total of 25 nodes showed eccentric cortical thickening with wide echogenic hilum and oval shape. In total, 19 nodes showed asymmetric eccentric cortical thickening with wide echogenic hilum and oval shape. Overall, 10 nodes showed concentric cortical thickening with reduction in the width of the echogenic hilum and oval shape. A total of four nodes showed huge reduction and displacement of the echogenic hilum and round or oval shape. No anomaly was found at the Doppler echocolor study. In conclusion, eccentric cortical thickening with wide echogenic hilum and oval shape, asymmetric eccentric cortical thickening with wide echogenic hilum and oval shape, concentric cortical thickening with reduction in the width of the echogenic hilum and oval shape, and a huge reduction and displacement of the echogenic hilum and round shape are the features that we found in post Covid-19 Vaccine lymphadenopathies.